Osteogenic Differentiation Potential of Human Bone Marrow and Amniotic Fluid-Derived Mesenchymal Stem Cells in Vitro & in Vivo
Author(s) -
Eman Mohammed,
Mohamed El-Zawahry,
Abdel Razik H. Farrag,
Nahla Abdelaziz,
Wessam E. SharafEldin,
Nourhan Abu-Shahba,
Marwa Mahmoud,
Khaled R. Gaber,
Taher Ismail,
Mohamed M. Mossaad,
Alice Abdel Aleem
Publication year - 2019
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2019.124
Subject(s) - mesenchymal stem cell , medicine , stem cell , amniotic fluid , progenitor cell , stem cell transplantation for articular cartilage repair , regenerative medicine , bone marrow , amniotic stem cells , regeneration (biology) , pathology , cell therapy , clinical uses of mesenchymal stem cells , adult stem cell , embryonic stem cell , microbiology and biotechnology , fetus , biology , pregnancy , biochemistry , genetics , gene
Cell therapies offer a promising potential in promoting bone regeneration. Stem cell therapy presents attractive care modality in treating degenerative conditions or tissue injuries. The rationale behind this is both the expansion potential of stem cells into a large cell population size and its differentiation abilities into a wide variety of tissue types, when given the proper stimuli. A progenitor stem cell is a promising source of cell therapy in regenerative medicine and bone tissue engineering.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom